1. Home
  2. RGEN vs XP Comparison

RGEN vs XP Comparison

Compare RGEN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.51

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo XP Inc.

XP

XP Inc.

HOLD

Current Price

$16.02

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
XP
Founded
1981
2001
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.3B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RGEN
XP
Price
$162.51
$16.02
Analyst Decision
Buy
Strong Buy
Analyst Count
10
5
Target Price
$174.90
$22.80
AVG Volume (30 Days)
701.7K
7.6M
Earning Date
10-28-2025
11-17-2025
Dividend Yield
N/A
1.12%
EPS Growth
N/A
18.53
EPS
0.03
1.76
Revenue
$707,890,000.00
$3,229,174,949.00
Revenue This Year
$17.84
$17.71
Revenue Next Year
$12.57
$13.05
P/E Ratio
$5,259.20
$9.08
Revenue Growth
11.74
8.33
52 Week Low
$102.97
$10.82
52 Week High
$182.52
$20.64

Technical Indicators

Market Signals
Indicator
RGEN
XP
Relative Strength Index (RSI) 54.15 35.35
Support Level $156.01 $15.63
Resistance Level $165.02 $18.12
Average True Range (ATR) 4.65 0.69
MACD -1.07 -0.33
Stochastic Oscillator 43.33 8.39

Price Performance

Historical Comparison
RGEN
XP

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: